Abstract
The hepatitis C virus RNA-dependent RNA polymerase NS5B is responsible for the replication of the viral genome. Previous studies have uncovered NTP-mediated excision mechanisms that may be responsible for aiding in maintaining fidelity (the frequency of incorrect incorporation events relative to correct), but little is known about the fidelity of NS5B. In this study, we used transient-state kinetics to examine the mechanistic basis for polymerase fidelity. We observe a wide range of efficiency for incorporation of various mismatched base pairs and have uncovered a mechanism in which the rate constant for pyrophosphate release is slowed for certain misincorporation events. This results in an increase in fidelity against these specific misincorporations. Furthermore, we discover that some mismatches are highly unfavorable and cannot be observed under the conditions used here. The calculated fidelity of NS5B ranges between 10−4–10−9 for different mismatches.
Keywords: hepatitis C virus (HCV), NS5B, enzyme kinetics, RNA polymerase, polymerase fidelity, viral polymerase, pre-steady-state kinetics
Polymerase fidelity plays an important role in maintaining the integrity of the genome during replication. Viral polymerases face a unique challenge in balancing a sufficiently high fidelity to reduce the frequency of lethal mutations while still allowing for sufficient genetic variation for the virus to escape the host immune response and evolve resistance against antiviral therapeutics. Although extensive analysis has revealed the mechanism and kinetic basis for fidelity of DNA-dependent DNA polymerases, few studies have quantified the fidelity of RNA-dependent RNA polymerases including HCV (1). In particular, very little quantitative data are available to define the SARS-coronavirus fidelity (2–4) or the kinetics of nucleotide incorporation in vitro (5, 6).
In vivo measurements of HCV RNA viral replication show a mutation rate in the range of 10−6–10−4 substitutions/nucleotide site/cell infection (7, 8). Average measurements of the mutation rate of the hepatitis C virus (HCV) are 3.5 × 10−5 substitutions/nucleotide site/cell infection, indicating an average substitution of 0.36 mutations/genome replication cycle (2). These measurements, however, are biased against lethal mutations and may not reflect the true fidelity of the HCV RNA-dependent RNA polymerase (NS5B). Attempts to measure the fidelity of NS5B using in vitro methods have been previously published (1). In this method, an RNA template was designed so that NS5B will extend a dinucleotide primer using two of the four nucleotides up to 15 nucleotides and then pause because of the absence of the next complementary nucleotide. However, in prior studies the elongation complex was not isolated from unincorporated nucleotide used during the de novo initiation process, and the studies were conducted at a low NaCl concentration in which the active elongation complex is insoluble, which can complicate analysis of single-nucleotide incorporation. Here, we explore the fidelity of NS5B by measuring the kinetics of all 12 possible misincorporations using an isolated NS5B/9-nt primer/20-nt template elongation complex in an optimized buffer. Using these methods, we show that the rates of misincorporation vary widely for different mismatches. In addition, we found that the initial rate measurements underestimate the range of fidelity because of a previously unknown slow pyrophosphate release step seen with four of the mismatches. This slow pyrophosphate release allows for the reversal of chemistry to occur and contributes an increase in fidelity up to two orders of magnitude.
Results
To probe NS5B fidelity, a pre-steady-state kinetic analysis was performed to characterize incorporation of the four complementary nucleotides to serve as a basis for comparison with all 12 misincorporation events. The kinetics of the incorporation of complementary nucleotides allowed for the determination of the kinetic parameters kpol and Kd, app to afford calculation of kcat/Km. For measurement of misincorporation, the results are separated into two groups: low-fidelity misincorporations and high-fidelity misincorporations. Lower fidelity afforded estimates of kcat, Km, and kcat/Km, whereas higher-fidelity misincorporations only afforded estimates of kcat/Km, or in some cases, showed no evidence for misincorporation.
Correct incorporation of NTP
Correct incorporation of CTP:G and UTP:A (G and A are the templating bases) were previously measured and reported (9). Incorporation of ATP:U and GTP:C were measured by rapidly mixing the NS5B/9-nt/20-nt elongation complex with the complementary nucleotide using rapid quench-flow methods. The data were fit globally using Scheme 1 to determine the apparent equilibrium dissociation constant for ground-state binding (Kd, app = k−1/k1), the maximum rate of incorporation (kpol = kcat = k2), and the specificity constant for correct incorporation (kcat/Km = kpol/Kd, app). The results for these incorporation reactions are summarized on Table 1. The results for incorporation of ATP:U and GTP:C are shown in Fig. 1, A and B, respectively. The apparent affinity for ATP is the weakest of the four nucleotides (Kd, app = 572 ± 88 μm). This weak apparent affinity can be overcome by the high concentration of ATP in the cell (∼3 mm) (10). The rate constant of incorporation kpol was measured to be 8 ± 1 s−1. These results give a kpol/Kd,app of 0.014 ± 0.003 μm−1s−1, the lowest of the four correct incorporations, but commensurate with the high cellular ATP concentrations. The kinetic parameters of GTP:C incorporation were similar to CTP:G. The apparent affinity was determined to be 15 ± 3 μm, and kpol was measured to be 15 ± 1 s−1. GTP has the highest specificity (kpol/Kd,app = 1 ± 0.2 μm−1s−1) compared with ATP, UTP, and CTP.
Scheme 1.
Minimal model for misincorporation of nucleoside triphosphate by NS5B.
Table 1.
Kinetic parameters for incorporation of complementary nucleotide triphosphates
Rate constants were derived by fitting data in Fig. 1, A and B using Scheme 1. Standard errors were derived by nonlinear regression in globally fitting the data.
| Nucleotide | Kd,app (μm) | kpol (s−1) | kpol/Kd,app (μm−1s−1) |
|---|---|---|---|
| CTP:Ga | 26 ± 3 | 10 ± 0.8 | 0.38 ± 0.05 |
| UTP:Aa | 320 ± 60 | 33 ± 5 | 0.10 ± 0.02 |
| ATP:U | 572 ± 88 | 8 ± 1 | 0.014 ± 0.003 |
| GTP:C | 15 ± 3 | 15 ± 1 | 1 ± 0.2 |
aRate constants are from Villalba et al., 2019 (9).
Figure 1.
Incorporation of ATP and GTP by NS5B. The above plots show the incorporation of (A) ATP (15.6, 31.3, 62.5, 125, 250, and 500 µm, red to magenta) and (B) GTP (6.3, 12.5, 25, 50, and 100 µm, red to cyan). Incorporation was measured by rapid quench-flow methods and fit globally using Scheme 1 by KinTek Explorer. The solid lines show the best-fit results. Kinetic parameters are summarized in Table 1.
Data to define the specificity constant for correct base incorporation provide the standard for estimating fidelity from measurements of misincorporation kinetics. Fidelity is defined as the ratio of kcat/Km values for correct versus incorrect base pairs:
| (Eq. 1) |
Low-fidelity misincorporations
Low-fidelity misincorporations were classified based on the following criteria: 1) the time-dependence of the reaction reached the same endpoint for all NTP concentrations, so that no amplitude dependence was observed (Fig. 2, A and B); 2) plotting the rate versus NTP concentration shows a hyperbolic dependence (Fig. 2C) and therefore indicates fast pyrophosphate release that is not rate-limiting; and (3) the fidelity was in the range of 10−4. Fitting the family of curves globally using Scheme 1 yields the maximum rate of polymerization (kpol = k2) and the apparent equilibrium NTP dissociation constant (Kd, app = k−1/k1), allowing for calculation of the specificity constant for misincorporation (kcat/Km = kpol/Kd, app). These efficient misincorporation reactions led to the lowest fidelity of the 12 possible mismatches. The kinetic parameters for these misincorporations are summarized in Table 2.
Figure 2.

Example of analytical fit of low-fidelity misincorporations. The above plots show and example of fitting a low-fidelity misincorporation (CTP:A) using analytical functions. A, the product versus concentration fit to a single exponential function demonstrating all concentrations go to the same end point. B, when plotting the amplitude versus concentration, no change in amplitude with increasing concentration is observed. C, the rate increases hyperbolically as a function of concentration, allowing the data to be fit to obtain estimates of Kd, app and k2.
Table 2.
Kinetic parameters for low-fidelity misincorporations.
Rate constants are from data in Fig. 2, A–D. Fidelity is calculated using Equation 1 for each misincorporation relative to correct nucleotide incorporation
| Template base | Incoming base | Kd, app (µm) | Kpol (s−1) | Kpol/Kd, app (µm−1s−1) | Fidelity |
|---|---|---|---|---|---|
| A | Ua | 320 ± 60 | 33 ± 5 | 0.10 ± 0.02 | 1 |
| C | 7600 ± 1000 | 0.36 ± 0.04 | (4.7 ± 0.8) × 10−5 | (4.6 ± 1) × 10−4 | |
| C | G | 15 ± 3 | 15 ± 0.9 | 0.99 ± 0.2 | 1 |
| A | 2800 ± 400 | 0.41 ± 0.04 | (1.5 ± 0.3) × 10−4 | (1.5 ± 0.4) × 10−4 | |
| U | A | 570 ± 90 | 8 ± 1 | 0.014 ± 0.003 | 1 |
| G | 7700 ± 300 | 0.017 ± 0.002 | (2.2 ± 0.2) × 10−6 | (1.5 ± 0.3) × 10−4 | |
| U | 20,000 ± 2000 | 0.089 ± 0.01 | (4.5 ± 0.6) × 10−6 | (3.2 ± 0.8) × 10−4 |
a Rate constants for correct incorporation are from Villalab et al., 2019 (9).
Four misincorporation reactions were classified as low-fidelity: CTP:A (Fig. 3A), ATP:C (Fig. 3B), GTP:U (Fig. 3C), and UTP:U (Fig. 3D). Of the four, CTP:A and ATP:C were most efficiently misincorporated. For CTP:A, weak apparent binding was observed (Kd,app = 7.6 ± 1 mm), and the maximum rate constant of polymerization was 100-fold lower compared with correct incorporation (kpol = 0.36 ± 0.04 s−1). This gives a specificity constant of (4.7 ± 0.8) × 10−5 μm−1s−1. Fidelity for this mismatch is determined by comparison to UTP:A correct incorporation to be (4.6 ± 1) × 10−4 (∼1 error of every 2200 base pairs). The apparent affinity for an ATP:C misincorporation was ∼3-fold tighter than the converse (CTP:A) mismatch (Kd,app = 2.8 ± 0.4 mm), whereas the rate constant of misincorporation was ∼37-fold slower compared with correct incorporation with a kpol = 0.41 ± 0.04 s−1. This misincorporation is more efficient than CTP:A (kpol/Kd,app = (1.5 ± 0.3) × 10−4 μm−1s−1). However, because of the high efficiency of GTP incorporation (kpol/Kd,app = 0.99 ± 0.2 μm−1s−1), ATP:C has a similar fidelity to CTP:A ((1.5 ± 0.4) × 10−4; ∼1 error in 6700).
Figure 3.
Four low-fidelity misincorporations by NS5B. The plots show the four misincorporation reactions that are classified as low-fidelity: (A) CTP:A, (B) ATP:C, (C) GTP:U, and (D) UTP:U (500, 1000, 2000, 4000, and 5000 µm NTP). The designation CTP:A represents incorporation of CTP opposite a template A, for example. The data were fit globally using Scheme 1 using KinTek Explorer. The solid lines show the best-fit results from fitting. Kinetic parameters are summarized in Table 2.
Interestingly, the GTP:U wobble mismatch had one of the lowest specificity constants of the four in this category. A weak apparent affinity was observed (Kd, app = 7.7 ± 0.3 mm), as was the slowest rate of polymerization of the four (kpol = 0.017 ± 0.002 s−1; ∼470-fold slower compared with correct incorporation). This results in GTP:U mismatches being less favorable than CTP:A and ATP:C mismatches (kpol/Kd, app = (2.2 ± 0.2) × 10−6 μm−1s−1). UTP:U mismatches were shown to be as efficiently incorporated as GTP:U, but UTP:U had a Kd, app = 20 ± 2 mm, the weakest of the four in this group, although the rate constant of polymerization was greater (kpol = 0.089 ± 0.01 s−1) than GTP:U. Both UTP:U and GTP:U mismatches have similar specificity constants, kpol/Kd, app (UTP:U = (4.5 ± 0.6) × 10−6 μm−1s−1). Because correct incorporation of ATP has the lowest specificity constant of the four correct incorporations (kpol/Kd, app = 0.014 μm−1s−1), misincorporation of GTP:U and UTP:U showed fidelity similar to the rest of the misincorporations in this category ((1.5 ± 0.3) × 10−4 and (3.2 ± 0.8) × 10−4, respectively).
High-fidelity misincorporations
High-fidelity misincorporations are broken down into two subcategories: 1) no misincorporation observed and 2) slow pyrophosphate release. For those misincorporation reactions in which no extension of the 9-nt primer was observed by the end of the time course, we set a lower limit of detectable incorporation at 1% of the starting material after incubation with 5 mm nucleotide for 900 s. This allowed estimation of an upper limit on the rate of misincorporation to afford maximal estimates of kcat/Km values (Table 3). Four misincorporations fall under this subcategory: GTP:G (Fig. 4A), GTP:A (Fig. 4B), CTP:C (Fig. 4C), and CTP:U (Fig. 4D). We set a lower limit of Km for these misincorporations at ≥5 mm nucleotide and an upper limit for the rate constant of polymerization (k2) at ≤0.00002 s−1. This gives an estimated kcat/Km value of ≤4 × 10−9 μm−1s−1. Using these estimations, we calculate fidelity of ≤1 × 10−8 for GTP:G (≤1 in 90,000,000), ≤3.9 × 10−8 for GTP:A (≤1 in 26,000,000), ≤4 × 10−9 for CTP:C (≤1 in 240,000,000), and ≤2.9 × 10−7 for CTP:U (≤1 in 3,000,000). Averaging these misincorporations by the frequency of their respective bases in the HCV genome, these would occur only once in every 1400–83,000 replication cycles. It is quite possible that these results may change as a function of local RNA sequence.
Table 3.
Kinetic parameters of high-fidelity misincorporations
Rate constants are from estimates from Fig. 4 and fitting data in Fig. 6. Fidelity and specificity were calculated using Equation 1 and Equation 2, respectively.
| Template base | Incoming base | Kd, app (µm) | k2 (s−1) | k−2 (s−1) | k3 (s−1) | Kcat/Km (µm−1s−1) | Fidelity |
|---|---|---|---|---|---|---|---|
| G | Ca | 26 ± 3 | 10 ± 0.8 | – | – | 0.38 ± 0.05 | 1 |
| A | 4000 ± 500 | 0.0045 ± 0.0006 | 0.0081 ± 0.001 | 0.00057 ± 0.0001 | (7.4 ± 2) × 10−8 | (2.0 ± 0.8) × 10−7 | |
| U | 6000 ± 1000 | 0.014 ± 0.002 | 0.015 ± 0.002 | 0.0021 ± 0.0006 | (2.9 ± 1) × 10−7 | (7.8 ± 3) × 10−7 | |
| Gb | ≥ 5000 | ≤ 0.00002 | – | – | 4 × 10−9 | 1.1 × 10−8 | |
| C | G | 15 ± 3 | 15 ± 0.9 | – | – | 0.99 ± 0.19 | 1 |
| U | 3700 ± 600 | 0.022 ± 0.004 | 0.017 ± 0.007 | 0.0066 ± 0.003 | (1.6 ± 0.7) × 10−6 | (1.7 ± 0.8) × 10−6 | |
| Cb | ≥ 5000 | ≤ 0.00002 | – | – | 4 × 10−9 | 4.1 × 10−9 | |
| A | Ua | 320 ± 60 | 33 ± 5 | – | – | 0.1 ± 0.02 | 1 |
| A | 4700 ± 600 | 0.0048 ± 0.0006 | 0.0021 ± 0.0004 | ≤ 0.0017 | (4.6 ± 1) × 10−7 | (4.4 ± 2) × 10−6 | |
| Gb | ≥ 5000 | ≤ 0.00002 | – | – | 4 × 10−9 | 3.9 × 10−8 | |
| U | A | 570 ± 90 | 8 ± 1 | – | – | 0.014 ± 0.003 | 1 |
| Cb | ≥ 5000 | ≤ 0.00002 | – | – | 4 × 10−9 | 2.9 × 10−7 |
a Rate constants for correct incorporation are from Villalab et al., 2019 (9).
b Limits are set by estimating 1% substrate turnover by the end of the observed time course.
Figure 4.
Misincorporation reactions with no observed primer extension. The above show the 16% denaturing PAGE analysis of the (A) GTP:G, (B) GTP:A, (C) CTP:C, and (D) CTP:U at 5 mm nucleotide concentration. No significant amounts of primer extension above background were observed after 900 s for any of these four misincorporations. Upper limits were defined by estimating at most 1% extension by the end of the time course. Kinetic parameters are summarized on Table 3.
The second subcategory in this group shows a slow rate constant of pyrophosphate release (k3 in Scheme 1), which leads to slower net rates of misincorporation. The kinetics of incorporation are biphasic (Fig. 5A), and the amplitude of the fast reaction phase increases hyperbolically as a function of increasing concentrations of nucleotide (Fig. 5B). The amplitude dependence on NTP concentration implies that incorporation is reversibly linked to nucleotide binding. Because pyrophosphate release is largely irreversible at the concentrations formed during a single turnover, the amplitude dependence can be attributed to a slow rate constant for pyrophosphate release allowing polymerization (k2) and the reverse of chemistry (k−2) to come to equilibrium linked to nucleotide binding. This behavior has been observed in other polymerases such as 8-oxo-dGTP incorporation by human mitochondrial polymerase γ (11) and by HIV RT when reverse transcribing an RNA template (12) but to the best of our knowledge has not been observed in HCV NS5B.
Figure 5.
Example of misincorporation reactions showing slow pyrophosphate release. The plots show (A) the biphasic curves and (B) hyperbolic increase of amplitude as a function of nucleotide concentration that are characteristic of misincorporations with slow pyrophosphate release (UTP:G used as an example here). C, the confidence contour analysis of UTP:G misincorporation demonstrates a good fit to define all four parameters within the confidence intervals generated with well-defined upper and lower boundaries. This indicates that the data are sufficient to provide estimates of four rate constants according to Scheme 1: k−1 (to compute K1), k2, k−2, and k3.
The concentration dependence of the observed rate and amplitude of the reaction affords resolution of the forward and reverse rate constants for the chemistry step and the rate constant for pyrophosphate release, supported by confidence contour analysis (Fig. 5C) (25). This slower rate constant of pyrophosphate release serves to lower kcat/Km by allowing reversal of chemistry and release of the bound nucleotide, thereby increasing fidelity as described below.
The four misincorporations that are classified in this subcategory are ATP:G (Fig. 6A), UTP:G (Fig. 6B), UTP:C (Fig. 6C), and ATP:A (Fig. 6D). The kinetic parameters are summarized in Table 3. All four misincorporations showed weak apparent nucleotide affinities compared with the Kd, app of their respective correct incorporation reactions. The weakest apparent affinity was UTP:G (Kd, app = 6 ± 1 mm), followed by ATP:A (Kd, app = 4.7 ± 0.6 mm), ATP:G (Kd, app = 4 ± 0.5 mm), and finally UTP:C (Kd, app = 3.7 ± 0.6 mm). The ATP:G misincorporation showed the highest fidelity of the four in this subcategory. This is attributable to the rate constant for the reverse of chemistry (k−2 = 0.0081 ± 0.001 s−1) greater than the forward reaction (k2 = 0.0045 ± 0.0006 s−1). The rate constant of pyrophosphate release is also the slowest compared with the other three misincorporations in this category (k3 = 0.00057 ± 0.0001 s−1).
Figure 6.
Four incorporations with a slow rate constant of pyrophosphate release. The above plots show the four misincorporations with a slow pyrophosphate release step. (A) ATP:G (250, 500, 1000, 2000, 4000 µm ATP), (B) UTP:G (500, 1000, 2000, 4000 µm UTP), (C) UTP:C (500, 1000, 2000, 4000, 5000 µm UTP), and (D) ATP:A (500, 1000, 2000, 4000, 5000 µm ATP) were fit globally in KinTek Explorer using Scheme 1. The lines show the best-fit results from fitting. Kinetic parameters are summarized in Table 2.
Including pyrophosphate release in the model leads to the following equation for the specificity constant:
| (Eq. 2) |
When k−2 < k3, kcat/Km = K1k2.
Using Equation 1, kcat/Km for this misincorporation was calculated to be (7.4 ± 2) × 10−8 μm−1s−1. This gives a fidelity of (2 ± 0.8) × 10−7, ∼1 in 5,000,000 base pairs. Interestingly, the UTP:G wobble base pair had the second highest fidelity relative to the other three. The maximum rate constant of incorporation and the reverse of chemistry are almost identical (k2 = 0.014 ± 0.002 s−1 and k−2 = 0.015 ± 0.002 s−1), with the reverse reaction being slightly favored over the forward (K2 = 0.93). These result in a kcat/Km of (2.9 ± 1) × 10−7 μm−1s−1 and a fidelity of (7.8 ± 3) × 10−7 (∼1 in 1,300,000).
UTP:C misincorporations showed the fastest rate constants for incorporation and pyrophosphate release relative to the other three in this subcategory. The rate constant for incorporation was measured to be 0.022 ± 0.004 s−1. The reverse of chemistry is slightly slower (k−2 = 0.017 ± 0.007 s−1), indicating that the equilibrium lies slightly in the forward direction (K2 = 1.2). The rate constant of pyrophosphate release was determined to be 0.0066 ± 0.003 s−1, ∼2.6-fold slower than the reverse of chemistry. Taken together, these results give a calculated kcat/Km of (1.6 ± 0.7) × 10−6 μm−1s−1 and a fidelity of (1.7 ± 0.8) × 10−6 (∼1 in 600,000).
The lowest fidelity of these four is ATP:A misincorporations. This is because of a faster rate constant of chemistry (k2 = 0.0048 ± 0.0006 s−1) relative to the reverse reaction (k−2 = 0.0021 ± 0.0004 s−1). We were only able to set an upper limit on the rate constant of pyrophosphate release, but it was determined to be comparable with the reverse reaction (k3 ≤ 0.0017 s−1). The calculated kcat/Km was determined to be (4.6 ± 1) × 10−7 μm−1s−1, giving a fidelity measurement of (4.4 ± 2) × 10−6 (∼1 in 230,000).
Free energy profiles reveal the mechanistic basis for fidelity
Fig. 7 shows the free energy profiles for correct incorporation and the two cases of misincorporation with fast and slow pyrophosphate release. The rate-limiting step is given by the highest barrier relative to the preceding local minimum, whereas specificity is a function of steps leading up to the highest barrier overall, relative to the starting state. For example, for correct incorporation, step 2 (chemistry) is rate-limiting and the specificity constant is defined by K1k2. This is also true in the case of a misincorporation with fast pyrophosphate release. However, when pyrophosphate release is slow and rate-limiting, the question whether this affects specificity is based on the kinetic partitioning of the ER10.PPi state. The higher barrier for k3 relative to k−2 (the rate constant k−2 > k3) allows time for the reversal of chemistry and release of the bound nucleotide before pyrophosphate is released. This is expressed mathematically in Equation 2. When k−2 > k3, kcat/Km = K1K2k3. Under these conditions, slow pyrophosphate release reduces kcat/Km for misincorporation, thereby improving fidelity.
Figure 7.
Free energy profile for correct incorporation and misincorporation. The free energy profiles compare the kinetics for correct incorporation (CTP:G; green), UTP:G mismatch modeled with fast pyrophosphate release (blue), and UTP:G mismatch with rate-limiting pyrophosphate release and reversible chemistry (red). The steps leading to the highest energy barrier relative to the start determines specificity (kcat/Km). For correct incorporation and misincorporation with fast pyrophosphate release, K1k2 determines specificity, whereas specificity for rate-limiting pyrophosphate release is determined by K1K2k3.
Discussion
In this study, we explored the fidelity of NS5B by measuring the kinetics of incorporation of the cognate base pairs and all 12 mismatches. We used a pre-steady-state kinetic analysis to monitor the extension of a primer over time and fit the results globally using Scheme 1 using KinTek Explorer. From this we were able to determine the apparent equilibrium dissociation constant (Kd, app), the maximum rate constant of chemistry (kpol = k2), and in some cases, the reverse of chemistry (k−2) and rate constant of pyrophosphate release (k3). Using these results, and by using Equation 2 for mismatches that show slow pyrophosphate release, we are able to calculate the specificity constant (kcat/Km = kpol/Kd, app) for low-fidelity mismatches. The fidelity for each misincorporation was calculated by dividing the specificity constant for the misincorporation by the specificity constant of the correct incorporation for a given templating base (Equation 1).
Some similarities were observed between this work and previously reported results for incorporation by NS5B. The specificity constant for correct incorporation of CTP, UTP, and ATP were within 2-fold of each other, and both identify ATP as having the lowest specificity constant of the four incorporations. Also, both works not only identify the GTP:U wobble mismatch as one of the most likely mismatch to occur but also suggest that the reverse mismatch (UTP:G) is less likely to occur (1).
We found that under our conditions and using an isolated elongation complex, the fidelity of NS5B ranges from 10−4–10−9 depending on the incoming nucleotide and templating base. This range indicates that NS5B may have a higher fidelity than previously thought (10−3–10−6) (1). Furthermore, in contrast to these previously reported results, we identified four misincorporations that are more likely to occur than others and a mechanism for increasing fidelity previously unknown to NS5B. Normalizing each misincorporation by the frequency each base occurs in the HCV genome gives an average of 0.19 substitutions/genome replication cycle, ∼1.9-fold lower than in vivo measurements (2).
The four lowest fidelity misincorporations (CTP:A, ATP:C, GTP:U, and UTP:U) all had a fidelity in the 10−4 range. Each of these four misincorporations had a measured apparent nucleotide dissociation constant significantly higher than the physiological concentrations of ribonucleotides. This weak apparent affinity is especially key in discriminating against accumulation of UTP:U misincorporations. CTP:A and ATP:C showed a much faster rate constant of misincorporation of the four and also had the highest efficiency compared with the other two. These were also the most likely of the four to be extended after the misincorporation has occurred (data not shown). These four lower-fidelity mutations may account for mutations that lead to genetic drift.
Previous work measuring the misincorporation frequencies during replication of an HCV replicon indicate that NS5B preferentially makes transition mutations over transversion mutations (1). Three of the four low-fidelity misincorporations that lead to transition mutations (CTP:A, ATP:C, and GTP:U) are in agreement with this observation. However, we measured UTP:G mismatches to be higher-fidelity misincorporations. This difference may reflect an influence of local sequence context on the fidelity of a specific mismatch.
A U → A mutation is required for the S282T substitution that affords resistance to sofosbuvir, a nucleotide analog critical for treatment of HCV infections (13, 14). This mutation could arise because of a UTP:U mismatch during (−) strand synthesis or by an ATP:A mismatch during (+) strand synthesis. The UTP:U misincorporation occurs readily, but the weak apparent binding affinity cannot be saturated at the low physiological concentration of UTP relative to ATP (570 μm and 3 mm, respectively) (10). Moreover, the ratio of (+) strand RNA to (−) strand RNA in vivo can reach up to 1000:1 depending on the cell type (15–17). Therefore, it would be more likely for the misincorporation necessary to form the S282T resistance variant to occur during (+) strand synthesis with an ATP:A misincorporation. However, this misincorporation has a slow pyrophosphate release rate that increases discrimination against misincorporation. These results may explain why the S282T mutation has not been observed in clinical samples, although there are certainly many reasons for the failure to observe this mutation in the clinic.
Four misincorporation reactions were so largely unfavorable that they were not observed above background during our measurements (GTP:G, CTP:C, GTP:A, and CTP:U). We set limits on the rate constant of incorporation at ≤0.00002 s−1 to make an estimate on the fidelity of these four misincorporations. The fidelity ranged from 10−7–10−9. After normalizing these misincorporations by the frequency of the templating bases in the HCV genome, it is reasonable to assume that these mutations require a large viral population (such as during an active infection) to accumulate significantly. One possible explanation for these mismatches being so unfavorable is that NS5B may have evolved to heavily discriminate against these four misincorporations because of a possible lethal effect they may have. However, the exact reason for this large discrimination is still unclear, and more work needs to be done to address the effect these four misincorporations would have in vivo. We have not examined sequence context effects. It is possible that the mutation frequency may change as a function of sequence context, especially for those sites showing undetectable misincorporation. Nonetheless, our studies in a single-sequence context provide an order of magnitude estimate of fidelity and define the mechanistic basis for selectivity.
Interestingly, a slow rate constant of pyrophosphate release was observed for four misincorporation reactions (ATP:G, UTP:G, UTP:C, and ATP:A). The slow rate constant of pyrophosphate release allows the reverse of chemistry to occur, which increases the fidelity of these misincorporations by decreasing kcat/Km by up to two orders of magnitude. This phenomenon has not been previously observed in NS5B.
Fidelity of DNA polymerization catalyzed by HIV RT is a function of a nucleotide-induced conformational change preceding chemistry (18). It is not yet known whether a conformational change step may govern fidelity for NS5B. If it does, then our Kd, app values must be considered as Km values, not true Kd values (which was never intended in any case). The values measured would still be valid, but the interpretation for the mechanistic basis for understanding Km would change, as described for HIV RT (18, 19).
NS5B does not contain an exonuclease domain to correct misincorporations. However, we have previously demonstrated an ATP-mediated excision mechanism for removing nucleotides at the 3′-end of a primer strand (9, 20). It is unknown what contribution, if any, this excision reaction makes toward increasing fidelity. Our studies on measuring this effect have been limited by an inability to efficiently generate an elongation complex containing a mismatch at the 3′-end of a primer strand. Although we have yet to identify the contribution of this mechanism toward fidelity, our work has at least identified that NS5B is able to increase fidelity on certain base pairs by slowing down the release of pyrophosphate after the chemical step for misincorporation.
This work serves as a basis for understanding and measuring the fidelity of other viral RNA-dependent RNA polymerases, including the SARS-coronavirus-2. In particular, application of the methods outlined in this paper will better define the fidelity and the mechanism and specificity constant for incorporation of remdesivir triphosphate (5, 6) currently used to treat COVID-19 (21).
Experimental procedures
RNA templates, expression, and purification of NS5BΔ21
RNA templates and GG dimers used were obtained from Dharmacon (Chicago, IL) and were desalted and decapped prior to delivery. The sequences of the RNA oligomers used are shown in Table 4. NS5BΔ21 was expressed, purified, and stored at −80 °C as previously described (9). Throughout the text we refer to NS5BΔ21 as simply NS5B.
Table 4.
RNA templates
The underlined base indicates where the extension-and-pause reaction stops during NS5B/9-nt/20-nt elongation complex formation. The base in red indicates the templating base for single incorporation reaction.
| 20-nt CG template | 3′-CCUAUAUUAGCAAUAUCUAA-5′ |
| 20-nt UA template | 3′-CCUCUCUUCACAAUAUCUAA-5′ |
| 20-nt GC template | 3′-CCUAUAUUACGAAUAUCUAA-5′ |
| 20-nt AU template | 3′-CCACACAACUGAAUAUCUAA-5′ |
Replicates
All experiments were performed at least two times to ensure reproducibility of the results.
Assembly and purification of NS5BΔ21/9-nt primer/20-nt template elongation complex
The NS5B elongation complex with a 9-nucleotide primer and 20-nucleotide template (NS5B/9-nt/20-nt, Table 4) was assembled using an extension-and-pause set-up and initiated using either a 20 μm pG- or 1 mm GTP start method (9). All reactions were mixed in a buffer containing 40 mm Tris-HCl, pH 7.0, 20 mm NaCl, 5 mm DTT, and 2 mm MgCl2 and incubated at 30 °C for 90 min. At this concentration of NaCl, the elongation complex precipitates but remains intact and retains polymerase activity. For assembling the elongation complex with the 20-nt CG template, 12 μm NS5B was mixed with 20 μm RNA template, 1 mm GTP, 50 μm UTP, and 50 μm [α-32P]-ATP. For assembling the elongation complex with the 20-nt UA template (Table 4), 12 μm NS5B was mixed with 20 μm RNA template, 1 mm GTP, and 50 μm [α-32P]-ATP. For assembling the elongation complex with the 20-nt GC template, 10 μm NS5B was mixed with 20 μm RNA template, 20 μm pGG, 50 μm UTP, and 50 μm [α-32P]-ATP. For assembling the elongation complex with the 20-nt AU template, 10 μm NS5B was mixed with 20 μm RNA template, 20 μm pGG, 20 μm GTP, and 50 μm [α-32P]-UTP. After incubation, the precipitated complexes were isolated from excess substrates by centrifuging at 25,000 relative centrifugal force for 5 min using an Eppendorf benchtop centrifuge. The supernatant was discarded, and the pellets were washed twice by resuspending in a buffer containing 40 mm Tris-HCl, pH 7.0, 20 mm NaCl, 5 mm DTT, and 2 mm MgCl2 and centrifuging at 16,000 rpm for 5 mins. The purified complexes were resuspended in a buffer containing 40 mm Tris-HCl, pH 7.4, 150 mm NaCl, 5 mm DTT, and 2 mm MgCl2.
Incorporation and misincorporation of nucleoside triphosphates by NS5BΔ21
The elongation complex was assembled, washed, and resuspended in elongation buffer for each of the four RNA templates as previously described (22). To measure the rate constant of NTP incorporation, the elongation complex was rapidly mixed with a solution containing the complementary NTP using KinTek RQF-3 rapid quench-flow elongation buffer. Reactions were carried out at 30 °C and quenched with 50 mm EDTA. The rate constants for misincorporation are slow and therefore were measured by hand-mixing methods. Elongation complex was mixed with an equal volume of a solution containing the NTP in elongation buffer. Reactions were allowed to proceed at 30 °C, and 10-μl aliquots were removed from the reaction and mixed with 40 μl of 50 mm EDTA at given time points. The samples were heat denatured by incubating at 95 °C for 5 min and loaded onto a 16% polyacrylamide gel containing 7 m urea. Electrophoresis, drying, exposing, and quantification were performed as previously described (9).
Data analysis
The kinetics of nucleotide incorporation into a primer by NS5B were fit using KinTek Explorer based on a rapid equilibrium substrate binding mode (Scheme 1) (19, 23, 24). To determine the Kd, app for NTP, the rate constant of binding (k1) was assumed to be diffusion limited and locked at 100 μm−1s−1, and the rate constant of dissociation (k−1) was allowed to vary during fitting. The Kd, app was then determined by dividing the rate constant of dissociation by the rate constant of binding (Kd, app = k−1/k1). The maximum rate constant of polymerization at saturating nucleotide concentration was determined by allowing k2 to vary during the fitting process. For incorporation of complementary NTP, pyrophosphate release (k3) was assumed to be fast and not rate-limiting and was locked at 100 s−1. The rate constants for the reverse of chemistry (k−2) and rebinding of pyrophosphate (k−3) were modeled as irreversible steps and held constant at 0 s−1. For misincorporations that do not appear to be limited by the release of pyrophosphate, the rate constant of product release (k3) was locked at 100 s−1, and the reverse of chemistry (k−2) and pyrophosphate rebinding were modeled as irreversible steps by locking their rate constants at 0. For these reactions, the specificity constant (kcat/Km) was determined by dividing the rate constant of chemistry by the apparent equilibrium dissociation constant (kpol/Kd = k2/Kd, app). For misincorporations that have a slow pyrophosphate release, the reverse of chemistry (k−2) and the rate constant of pyrophosphate release (k3) were allowed to vary during the fitting process. Because of the low pyrophosphate concentration relative to nucleotide concentration, the rebinding of pyrophosphate was determined to be negligible and locked at 0. For these reactions, kcat/Km was determined by Equation 2 (11). Fidelity was determined by dividing the specificity constant of a misincorporation by the specificity constant for correct incorporation (Equation 1).
Data availability
All data generated during this study are included in this article.
Author contributions—B. V. conceptualization; B. V. and K. A. J. data curation; B. V. formal analysis; B. V. and K. A. J. investigation; B. V. methodology; B. V. writing-original draft; B. V. and K. A. J. writing-review and editing; K. A. J. resources; K. A. J. supervision; K. A. J. validation; K. A. J. project administration.
Funding and additional information—This work was supported by NIAID Grant 1R01AI110577 (to K. A. J.) and the Welch Foundation Grant F-1604 (to K. A. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Conflict of interest—K. A. J. is president of KinTek Corporation, which provided the RQF-3 rapid quench-flow instrument and KinTek Explorer software used in this study.
- HCV
- hepatitis C virus
- NS5B
- nonstructural protein 5B.
References
- 1. Powdrill M. H., Tchesnokov E. P., Kozak R. A., Russell R. S., Martin R., Svarovskaia E. S., Mo H., Kouyos R. D., and Götte M. (2011) Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance. Proc. Natl. Acad. Sci. U. S. A. 108, 20509–20513 10.1073/pnas.1105797108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Selisko B., Papageorgiou N., Ferron F., and Canard B. (2018) Structural and functional basis of the fidelity of nucleotide selection by flavivirus RNA-dependent RNA polymerases. Viruses 10, 59 10.3390/v10020059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Ferron F., Subissi L., Silveira De Morais A. T., Le N. T. T., Sevajol M., Gluais L., Decroly E., Vonrhein C., Bricogne G., Canard B., and Imbert I. (2018) Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proc. Natl. Acad. Sci. U. S. A. 115, E162–E171 10.1073/pnas.1718806115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Eckerle L. D., Becker M. M., Halpin R. A., Li K., Venter E., Lu X., Scherbakova S., Graham R. L., Baric R. S., Stockwell T. B., Spiro D. J., and Denison M. R. (2010) Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 6, e1000896 10.1371/journal.ppat.1000896 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Gordon C. J., Tchesnokov E. P., Feng J. Y., Porter D. P., and Götte M. (2020) The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J. Biol. Chem. 295, 4773–4779 10.1074/jbc.AC120.013056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Gordon C. J., Tchesnokov E. P., Woolner E., Perry J. K., Feng J. Y., Porter D. P., and Götte M. (2020) Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J. Biol. Chem. 295, 6785–6797 10.1074/jbc.RA120.013679 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Sanjuán R., Nebot M. R., Chirico N., Mansky L. M., and Belshaw R. (2010) Viral mutation rates. J. Virol. 84, 9733–9748 10.1128/JVI.00694-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Sanjuán R., and Domingo-Calap P. (2016) Mechanisms of viral mutation. Cell. Mol. Life Sci. 73, 4433–4448 10.1007/s00018-016-2299-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Villalba B., Li J., and Johnson K. (2020) Resistance to excision determines efficiency of inhibition of hepatitis C virus RNA-dependent RNA polymerase by nucleotide analogs including sofosbuvir. J. Biol. Chem. 295, 10112–10124 10.1074/jbc.RA120.013422 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Traut T. W. (1994) Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1–22 10.1007/BF00928361 [DOI] [PubMed] [Google Scholar]
- 11. Hanes J. W., Thal D. M., and Johnson K. A. (2006) Incorporation and replication of 8-Oxo-deoxyguanosine by the human mitochondrial DNA polymerase. J. Biol. Chem. 281, 36241–36248 10.1074/jbc.M607965200 [DOI] [PubMed] [Google Scholar]
- 12. Li A., Gong S., and Johnson K. A. (2016) Rate-limiting pyrophosphate release by HIV reverse transcriptase improves fidelity. J. Biol. Chem. 291, 26554–26565 10.1074/jbc.M116.753152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Migliaccio G., Tomassini J. E., Carroll S. S., Tomei L., Altamura S., Bhat B., Bartholomew L., Bosserman M. R., Ceccacci A., Colwell L. F., Cortese R., de Francesco R., Eldrup A. B., Getty K. L., Hou X. S., et al. (2003) Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem. 278, 49164–49170 10.1074/jbc.M305041200 [DOI] [PubMed] [Google Scholar]
- 14. Svarovskaia E. S., Dvory-Sobol H., Parkin N., Hebner C., Gontcharova V., Martin R., Ouyang W., Han B., Xu S., Ku K., Chiu S., Gane E., Jacobson I. M., Nelson D. R., Lawitz E., et al. (2014) Infrequent development of resistance in genotype 1–6 hepatitis C virus–infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials. Clin. Infect. Dis. 59, 1666–1674 10.1093/cid/ciu697 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Fong T., Shindo M., Feinstone S., Hoofnagle J., and di Bisceglie A. (1991) Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J. Clin. Invest. 88, 1058–1060 10.1172/JCI115368 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Lin L., Libbrecht L., Verbeeck J., Verslype C., Roskams T., van Pelt J., van Ranst M., and Fevery J. (2009) Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific real-time RT-PCR assays: methods and clinical relevance. J. Med. Virol. 81, 1569–1575 10.1002/jmv.21510 [DOI] [PubMed] [Google Scholar]
- 17. Revie D., and Salahuddin S. Z. (2011) Human cell types important for hepatitis C virus replication in vivo and in vitro. Old assertions and current evidence. Virol. J. 8, 346 10.1186/1743-422X-8-346 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Kellinger M. W., and Johnson K. A. (2010) Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 107, 7734–7739 10.1073/pnas.0913946107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Johnson K. A. (2019) Kinetic Analysis for the New Enzymology: Using computer simulation to learn kinetics and solve mechanisms, KinTek Corporation, Austin, U.S.A. [Google Scholar]
- 20. Jin Z., Leveque V., Ma H., Johnson K. A., and Klumpp K. (2013) NTP-mediated nucleotide excision activity of hepatitis c virus RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 110, E348–E357 10.1073/pnas.1214924110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Davis J. S., Ferreira D., Denholm J. T., and Tong S. Y. (2020) Clinical trials for the prevention and treatment of COVID-19: current state of play. Med. J. Aust. 213, 86–93 10.5694/mja2.50673 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Jin Z., Leveque V., Ma H., Johnson K. A., and Klumpp K. (2012) Assembly, purification, and pre-steady-state kinetic analysis of active RNA-dependent RNA polymerase elongation complex. J. Biol. Chem. 287, 10674–10683 10.1074/jbc.M111.325530 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Johnson K. A., Simpson Z. B., and Blom T. (2009) Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data. Anal. Biochem. 387, 20–29 10.1016/j.ab.2008.12.024 [DOI] [PubMed] [Google Scholar]
- 24. Johnson K. A. (2010) The kinetic and chemical mechanism of high-fidelity DNA polymerases. Biochim. Biophys. Acta 1804, 1041–1048 10.1016/j.bbapap.2010.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Johnson K. A., Simpson Z. B., and Blom T. (2009) FitSpace Explorer: an algorithm to evaluate multidimensional parameter space in fitting kinetic data. Anal. Biochem. 387, 30–41 10.1016/j.ab.2008.12.025 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated during this study are included in this article.







